Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.12 | N/A |
| PEG Ratio (TTM) | 2.44 | N/A |
| P/S Ratio (TTM) | 1.51 | N/A |
| P/B Ratio (TTM) | 2.77 | N/A |
| P/FCF Ratio (TTM) | 8.71 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.68 | N/A |
| Price to 5YR AVG FCF Ratio | 5.97 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.33% | N/A |
| ROE (TTM) | 17.65% | N/A |
| Net Profit Margin (TTM) | 9.97% | N/A |
| ROIC 5YR AVG | 8.97% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 326.97% | 9.88% | 52.04% |
| Revenue | -0.78% | 17.97% | 18.47% |
| Net Income | 328.41% | 9.65% | 51.21% |
| Cash Flow | 261.83% | 275.98% | 173.69% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.15 | N/A |
| Quick Ratio (TTM) | 1.44 | N/A |
| D/E Ratio (TTM) | 1.91 | N/A |
| Interest Coverage (TTM) | 2.78 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.64 | N/A |
| LTL to 5YR AVG FCF | 4.11 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.36% | N/A |